The Effect of Milk Components on the Response to the Pneumonia Vaccine in Senior Citizens

The Effect of Milk Components on the Response to the Pneumonia Vaccine in Senior Citizens: A Randomized Placebo-controlled Clinical Trial

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01626300

Enrollment

Registered

2012-06-22

Start date

2007-12-31

Completion date

2008-06-30

Last updated

2017-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The Effect of Milk Components on the Response to Pneumococcal Vaccines in the Elderly

Brief summary

The purpose of this study is to determine if the daily use of a certain amount and type of milk component for 2 months provides a significant stimulation to the immune system and specifically increases the chances of being protected against pneumonia after the vaccination.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

60 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Age and a willingness to participate

Exclusion criteria

* • Smoking history within 10 years * Underlying neoplasia or immunological disease * Use of oral cortisone or other immunosuppressive agents * Current consumption of milk and milk products greater than 1 unit of milk, 1 yogurt, or 1 serving of fresh cheese a day. * Food faddists or those taking a non-traditional diet * Current consumption of dietary supplements * People with a known history of milk allergy * People with chronic renal failure * People with chronic inflammatory diseases taking daily doses of NSAIDs for longer than 4 weeks at the time of enrollment. * Previous administration of the pneumomax vaccine * Reduced physical activity (i.e. NYHA classes III-IV)

Outcome results